Molecule intelOpportunity: Moderate0Crowded market

Water For

117 brands · 44 companies · product forms

1 DRAP alert

Opportunity snapshot

Launch attractiveness
39
Market saturation
93
Price room
100
Regulatory risk
50
117
brands
44
companies
Rs 23.52
median price
226
price points
495.92x
price spread
90
confidence %

Who competes here

Top companies by brand count — fragmented market (no dominant player) · leader share 8%

Price room

Across observed sources and strengths
CheapestRs 3.88
MedianRs 23.52
Most expensiveRs 1,924.18
Spread495.92×
Sources: DRAP-official, DVAGO, Servaid

max/min price ratio 495.92x across 226 trusted points (Rs 3.88-1924.18). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory alerts

Recall exposurelatest 2026-02-12
01. Recall Alert (Class-I) – Drug Products tested by DTL Punjab.

Why this score

Launch attractiveness

40% supply-gap(20) + 25% price-variation(100) + 20% low-competition(7) + 15% supply-disruption(40), damped by confidence(90). Higher = more attractive, less crowded opportunity.

Market saturation

44 canonical companies and 117 brands compete (saturation pegged at 30 companies / 150 brands).

Price room

max/min price ratio 495.92x across 226 trusted points (Rs 3.88-1924.18). NOTE: mixes strengths (graph prices carry no strength), so treat as indicative.

Regulatory risk

1 DRAP alert(s), latest 2026-02-12 incl. recall/safety.

Confidence

Reduced by: no ATC code.

Packaged brief for this moderate opportunity?

Molecule page + company profiles + price-room analysis are the pilot package for pharma teams.

See packaged reports All 3868 molecules

Molecule intelligence as of 2026-07-30. Brand/company counts from DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.